financetom
Business
financetom
/
Business
/
--FB Financial Raises Quarterly Dividend $0.02 to $0.19 a Share, Payable Feb. 25 to Holders Feb. 11
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--FB Financial Raises Quarterly Dividend $0.02 to $0.19 a Share, Payable Feb. 25 to Holders Feb. 11
Jan 29, 2025 12:38 PM

03:18 PM EST, 01/29/2025 (MT Newswires) --

Price: 52.46, Change: -0.31, Percent Change: -0.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
May 31, 2024
On Friday, the FDA approved Moderna Inc’s mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine to protect adults aged 60 and older from lower respiratory tract disease caused by RSV infection. The approval was granted under a breakthrough therapy designation and marks the second approved mRNA product from Moderna ( MRNA ), the first being the famed COVID-19 vaccine....
CAE Ratings Affirmed by S&P
CAE Ratings Affirmed by S&P
May 31, 2024
01:17 PM EDT, 05/31/2024 (MT Newswires) -- S&P Global Ratings on Friday affirmed its ratings on CAE (CAE.TO), including its BBB- issuer credit rating on the company. The rating affirmation comes after CAE reported a re-baselining of its defense business, along with defense impairment charges and contract adjustments related to eight previously identified fixed-price legacy contracts. The stable outlook reflects...
Fairfax Financial Holdings' Re/Insurance Subs Upgraded by S&P
Fairfax Financial Holdings' Re/Insurance Subs Upgraded by S&P
May 31, 2024
01:16 PM EDT, 05/31/2024 (MT Newswires) -- S&P Global Ratings said Friday that it upgraded ratings on Fairfax Financial Holdings' ( FRFHF ) core re/insurance subsidiaries to A+ from A and on the holding company, Fairfax Financial Holdings ( FRFHF ) to BBB+ from BBB. The upgrade follows S&P's revised criteria for analyzing insurers' risk-based capital. The implementation of the...
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
May 31, 2024
01:21 PM EDT, 05/31/2024 (MT Newswires) -- Pfizer ( PFE ) said Friday its Lorbrena drug for an advanced form of lung cancer helped patients live longer without disease progression, based on long-term follow-up results of a late-stage trial. Roughly 60% of patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer and treated with Lorbrena were alive without disease...
Copyright 2023-2026 - www.financetom.com All Rights Reserved